Leaking Containers Lead to Sodium Chloride Injection Recall

Article

Baxter is recalling 1 lot of its 0.9% sodium chloride injection due to customer complaints of leaking containers, particulate matter, and missing port protectors, which could result in contamination.

Baxter is recalling 1 lot of its 0.9% sodium chloride injection due to customer complaints of leaking containers, particulate matter, and missing port protectors, which could result in contamination.

This recall affects product code 2B132N from lot number C964601, which was distributed nationwide between January 22, 2015, and February 12, 2015, and expires on April 30, 2016.

To date, no adverse events associated with this recalled lot have been reported to Baxter. However, injecting a product containing particulate matter in the absence of in-line filtration may result in blockage of blood vessels, which can lead to stroke, heart attack or damage to other organs. There is also potential for allergic reactions, local irritation, and inflammation in tissues and organs.

Baxter has notified customers of this recall via letter, and the company is encouraging consumers to return the affected product. Adverse effects should be reported to the FDA’s MedWatch Adverse Event Reporting program.

Related Videos
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Medical team -- Image credit: Flamingo Images | stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.